Clinical Trial Update: Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting antiviral efficacy, pharmacokinetics and safety data for BILN 2061 ZW in chronic hepatitis C from Phase 1/2 studies that have co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BILN 2061 ZW (BILN-2061 ZW)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C, Chronic | Phase 1, Phase 2 | Status: COMPLETED